Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Colorectal Cancer: From Risk Factors to Oncogenesis. | Medicina (Kaunas) | 2023 | 37763765 | PubTator, text mining | PubMed |
| Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. | Int J Mol Sci | 2023 | 37762649 | PubTator, text mining | PubMed |
| Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors. | Genes (Basel) | 2023 | 37761922 | PubTator, text mining | PubMed |
| Case Series of 11 CDH1 Families (47 Carriers) Including Incidental Findings, Signet Ring Cell Colon Cancer and Review of the Literature. | Genes (Basel) | 2023 | 37761816 | PubTator, text mining | PubMed |
| Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022. | Curr Oncol | 2023 | 37754494 | PubTator, text mining | PubMed |
| A one-stop approach to diagnosing hereditary colorectal cancer in the Chinese population. | J Gastroenterol Hepatol | 2023 | 37749864 | PubTator, text mining | PubMed |
| Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome. | Front Oncol | 2023 | 37746257 | PubTator, text mining | PubMed |
| Aggressive variant prostate cancer: A case report and literature review. | World J Clin Cases | 2023 | 37731555 | PubTator, text mining | PubMed |
| Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN. | Front Immunol | 2023 | 37731500 | PubTator, text mining | PubMed |
| Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing. | Arthritis Res Ther | 2023 | 37730603 | PubTator, text mining | PubMed |
| Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study. | Hum Genet | 2023 | 37728764 | PubTator, text mining | PubMed |
| Combined germline and tumor mutation signature testing identifies new families with NTHL1 tumor syndrome. | Front Genet | 2023 | 37727376 | PubTator, text mining | PubMed |
| The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study. | Genome Med | 2023 | 37723522 | PubTator, text mining | PubMed |
| Prevalence of pathogenic germline variants in adult-type diffuse glioma. | Neurooncol Pract | 2023 | 37720399 | PubTator, text mining | PubMed |
| Molecular pathology of colorectal cancer: The Saudi situation in perspective. | Saudi Med J | 2023 | 37717975 | PubTator, text mining | PubMed |
| Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients. | Cancer Med | 2023 | 37694493 | PubTator, text mining | PubMed |
Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland. | Int J Mol Sci | 2023 | 37685988 | PubTator, text mining | PubMed |
| A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies. | J Clin Med | 2023 | 37685569 | PubTator, text mining | PubMed |
| Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC. | BMC Cancer | 2023 | 37679666 | PubTator, text mining | PubMed |
| Magnetic resonance imaging features of bile duct adenoma. | Front Oncol | 2023 | 37664063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=18